May.10

• Consolidated Financial Results for the Three Months ended March 31, 2012(192KB)

Apr.19

• AGC Announces Laying of Cornerstone at First Glass Manufacturing Facility in Brazil(89KB)

• AGC Glass Brazil announces social partnerships to Guaratinguetá and the Region(65KB)

• Statement regarding Media Report on AGC's Financial Results(7KB)

Apr.16

• AGC to boost its production capacity for Tafluprost, active pharmaceutical ingredient for glaucoma treatment - Responding to an expected increase in its sales volume following Merck's receipt of FDA approval to market glaucoma treatment in the U.S., etc. -(140KB)

Apr.12

• AGC releases "Sunbalance™ Aqua Green" and "Sunbalance™ Pure Clear"(196KB)

Apr.04

• World-leading Glass makerAGC to Invest in Advanced Nanotechnology Startup in U.S. Eyes nanostructured value-added glass via stake in Rolith, Inc. (145KB)

Mar.05

• AGC Succeeds in Developing Micro Hole Drilling Processing Technology for Ultra-thin Glass with a Thickness in the Order of Microns - Toward Application for Laminated Semiconductor Components -(154KB)

Feb.28

• AGC to establish a system toward reorganization of its domestic Chlor-Alkali business - making Hokkaido Soda into a subsidiary -(28KB)

Feb.08

• Consolidated Financial Results for the Fiscal Year ended December 31, 2011(330KB)

• Progress of the Mid-term Management Plan, and Group Policy for Addressing Changes in Business Environment - AGC aims to bring the Group's financial results back to a growth track by seizing changing environment as an opportunity for growth acceleration. -(162KB)

• Notice regarding Ordinary-Type Stock Options (Stock Acquisition Rights)(44KB)

• Concept and Policy on Reduction of Minimum Stock Trading Unit(7KB)

Feb.06

• Statement regarding Media Report on AGC's Financial Results, etc.(7KB)

Jan.23

• UV Verre Premium™ has been selected in Toyota Motor's Aqua as a beauty package option(70KB)